搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 小时
Astellas Pharma Inc.: Astellas' VYLOY (zolbetuximab-clzb) Approved by U.S. FDA for ...
VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Judge unseals new evidence
Preliminary cause of death
Challenges military listing
Nationwide blackout in Cuba
Frozen waffles recalled
Musk's first Trump event
Nevada US Senate debate
Fire prompts evacuations
PG&E shuts off power
NYC giant pigeon sculpture
NC breaks turnout record
NK sending troops to RU?
La Nina could arrive soon
Republicans appeal ruling
Opioid suits settlement deal
‘Full Self-Driving’ probe
Ex-MN congressman dies
At decade-high level
To furlough 700 workers
Eases voting rules
Three Americans detained
OK classroom Bible suit
$4M LAPD fentanyl seizure
Teen tobacco use falls
Bladder cancer drug pulled
US charges ex-Indian spy
FAA opens new safety review
Emergency abortion ruling
Calif. oil refinery closure
反馈